Shanghai Medicilon Inc (688202) - Total Liabilities

Latest as of March 2026: CN¥807.85 Million CNY ≈ $118.21 Million USD

Based on the latest financial reports, Shanghai Medicilon Inc (688202) has total liabilities worth CN¥807.85 Million CNY (≈ $118.21 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Shanghai Medicilon Inc (688202) net asset momentum to track the company's year-over-year net asset growth rate.

Shanghai Medicilon Inc - Total Liabilities Trend (2016–2025)

This chart illustrates how Shanghai Medicilon Inc's total liabilities have evolved over time, based on quarterly financial data. See Shanghai Medicilon Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Shanghai Medicilon Inc Competitors by Total Liabilities

The table below lists competitors of Shanghai Medicilon Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Abcellera Biologics Inc NASDAQ:ABCL	USA	$369.03 Million
Oil Refineries Ltd. TA:ORL	Israel	ILA2.56 Billion
Allied Gold Corporation NYSE:AAUC	USA	$1.27 Billion
Zhejiang Expressway Co. Ltd F:ZHJ	Germany	€200.36 Billion
Concentrix Corporation NASDAQ:CNXC	USA	$7.89 Billion
TECNOGLASS INC. DL-0001 F:7FH	Germany	€547.34 Million
Bank of Chongqing Co Ltd F:CQN	Germany	€967.73 Billion
Nations Technologies Inc SHE:300077	China	CN¥2.59 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Shanghai Medicilon Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688202 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.93	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.41	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.29	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Medicilon Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Medicilon Inc (2016–2025)

The table below shows the annual total liabilities of Shanghai Medicilon Inc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥687.85 Million ≈ $100.65 Million	+0.70%
2024-12-31	CN¥683.10 Million ≈ $99.96 Million	-9.53%
2023-12-31	CN¥755.07 Million ≈ $110.49 Million	+3.89%
2022-12-31	CN¥726.80 Million ≈ $106.35 Million	+55.94%
2021-12-31	CN¥466.06 Million ≈ $68.20 Million	+103.81%
2020-12-31	CN¥228.67 Million ≈ $33.46 Million	+79.02%
2019-12-31	CN¥127.73 Million ≈ $18.69 Million	+2.13%
2018-12-31	CN¥125.06 Million ≈ $18.30 Million	+22.27%
2017-12-31	CN¥102.29 Million ≈ $14.97 Million	+3.52%
2016-12-31	CN¥98.81 Million ≈ $14.46 Million	--

About Shanghai Medicilon Inc

SHG:688202 China Biotechnology

Market Cap

$1.61 Billion

CN¥10.99 Billion CNY

Market Cap Rank

#6936 Global

#1453 in China

Share Price

CN¥81.80

Change (1 day)

+3.34%

52-Week Range

CN¥51.31 - CN¥87.35

All Time High

CN¥394.88